Dr. Gi-Byoung Nam, Dr. Dukwoo Park and Dr. C Michael Gibson Discuss: EPIC-CAD – Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease September 1, 2024 Disclosures: TBD
Dr. Manesh Patel and Dr. C Michael Gibson Discuss: OCEANIC-AF – Asundexian versus apixaban in patients with atrial fibrillation September 1, 2024
Dr. Dirk-Jan van Ginkel and Dr. C Michael Gibson Discuss: POPular PAUSE TAVI – Continuation or interruption of oral anticoagulation during TAVI? August 31, 2024 Disclosures: TBD
Dr. Stefan James and Dr. C Michael Gibson Discuss: SWEDEGRAFT – No-touch vein grafts in coronary artery bypass grafting August 31, 2024 Disclosures: TBD
Dr. Jung-Min Ahn and Dr. C Michael Gibson Discuss: ASSURE DES – Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery August 31, 2024 Disclosures: TBD
Dr. Moritz Seiffert and Dr. C. Michael Gibson Discuss: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients At Low To Intermediate Risk: One Year Outcomes Of The Randomized DEDICATE-DZHK6 Trial April 19, 2024 Disclosures: TBD
Dr. Jung-Min Ahn, Dr. Duk-Woo Park and Dr. C. Michael Gibson Discuss: Preventive PCI Or Medical Therapy Alone For Atherosclerotic Coronary Vulnerable Plaques April 8, 2024 Disclosures: TBD
Dr. David Kandzari and Dr. C. Michael Gibson Discuss: Effect Of Alcohol-mediated Renal Denervation On Blood Pressure In The Presence Of Antihypertensive Drugs: 3-month Primary Results From The Target Bp I Randomized Trial April 8, 2024 Disclosures: TBD
Dr. Rasha Al-Lamee, Dr. Michael Foley and Dr. C. Michael Gibson Discuss: Coronary Sinus Reducer For The Treatment Of Refractory Angina: A Randomised, Placebo-controlled Trial (ORBITA-COSMIC) April 8, 2024 Disclosures: TBD
Dr. David Austin and Dr. C. Michael Gibson Discuss: Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: A Phase 3 Randomized, Open Label, Blinded Endpoint, Superiority Trial Of Enalapril To Prevent Anthracycline-induced Cardiotoxicity (PROACT) April 8, 2024 Disclosures: TBD
